| Hematopoietic stem cell gene therapy: progress and lessons learned RA Morgan, D Gray, A Lomova, DB Kohn Cell stem cell 21 (5), 574-590, 2017 | 226 | 2017 |
| Editing the sickle cell disease mutation in human hematopoietic stem cells: comparison of endonucleases and homologous donor templates Z Romero, A Lomova, S Said, A Miggelbrink, CY Kuo, ... Molecular therapy 27 (8), 1389-1406, 2019 | 97 | 2019 |
| Improving gene editing outcomes in human hematopoietic stem and progenitor cells by temporal control of DNA repair A Lomova, DN Clark, B Campo-Fernandez, C Flores-Bjurström, ... Stem cells 37 (2), 284-294, 2019 | 92 | 2019 |
| Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures NA Graham, A Minasyan, A Lomova, A Cass, NG Balanis, M Friedman, ... Molecular systems biology 13 (2), 914, 2017 | 77 | 2017 |
| JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma B Titz, A Lomova, A Le, W Hugo, X Kong, J Ten Hoeve, M Friedman, H Shi, ... Cell discovery 2 (1), 1-19, 2016 | 68 | 2016 |
| CRAF R391W is a melanoma driver oncogene M Atefi, B Titz, J Tsoi, E Avramis, A Le, C Ng, A Lomova, A Lassen, ... Scientific reports 6 (1), 27454, 2016 | 19 | 2016 |
| Global and local manipulation of DNA repair mechanisms to alter site-specific gene editing outcomes in hematopoietic stem cells EK Benitez, A Lomova Kaufman, L Cervantes, DN Clark, PG Ayoub, ... Frontiers in Genome Editing 2, 601541, 2020 | 9 | 2020 |
| Improving gene editing in human hematopoietic stem cells by temporal control of DNA repair A Lomova, DN Clark, Z Romero, RP Hollis, DB Kohn MOLECULAR THERAPY 26 (5), 87-88, 2018 | 2 | 2018 |
| Transient global inhibition of p53 in edited hematopoietic stem cells improves gene correction EK Benitez, L Cervantes, RP Hollis, Z Romero, DB Kohn Mol. Ther. 28, 2020 | 1 | 2020 |
| Preservation of Gene Edited Hematopoietic Stem Cells By Transient Overexpression of BCL-2 mRNA CF Bjurström, M Mojadidi, A Lomova, S Lai, S Fitz-Gibbon, M Pellegrini, ... Blood, The Journal of the American Society of Hematology 128 (22), 3636-3636, 2016 | 1 | 2016 |
| Gene editing of monogenic disorders in human hematopoietic stem cells--correction of x-linked agammaglobulinemia (xla) DB Kohn, CY Kuo, D Gray, ZR Garcia, RP Hollis, A Lomova US Patent App. 17/059,193, 2021 | | 2021 |
| The Effects of Manipulating DNA Repair Factors on CRISPR/Cas9-Mediated Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells A Lomova, EK Benitez, DN Clark, P Ayoub, Z Romero, RP Hollis, ... MOLECULAR THERAPY 27 (4), 352-352, 2019 | | 2019 |
| Improving Nuclease-Mediated Gene Editing Outcomes in Human Hematopoietic Stem Cells A Lomova University of California, Los Angeles, 2019 | | 2019 |
| Comparison of Endonucleases and DNA Donor Template Delivery Methods to Improve Site Specific Gene Correction in Hematopoietic Stem Cells Z Romero, A Miggelbrink, A Lomova, CY Kuo, B Campo-Fernandez, ... MOLECULAR THERAPY 26 (5), 84-84, 2018 | | 2018 |
